{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:28:38Z","timestamp":1787671718589,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2026,7,15]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Biologic augmentation, using substances like bone marrow aspirate concentrate (BMAC) and platelet-rich plasma (PRP), shows promise for improving outcomes in foot and ankle surgery, particularly in high-risk patients. Historically, autologous bone graft is the benchmark due to its trifecta of osteogenic, osteoinductive, and osteoconductive properties, despite its associated donor site morbidity. Current evidence supporting orthobiologics remains fragmented and inconclusive, with a lack of high-level randomized controlled trials (RCTs). BMAC shows fusion rates comparable to autograft in some foot and ankle applications, but PRP evidence is often conflicting due to a lack of preparation standardization. The regulatory environment is complex. The Food and Drug Administration (FDA) oversees human cells and tissues (HCT\/Ps) through a tiered system: high-risk \u00a7351 products (eg, cultured stem cells) require rigorous premarket approval, whereas \u00a7361 products (eg, allograft bone) have minimal oversight. BMAC and PRP often bypass this through the Same Surgical Procedure Exemption or are regulated through their processing devices, meaning the biologics themselves are not FDA-approved therapeutics. This regulatory gap and direct-to-consumer marketing necessitate meticulous informed consent, transparently discussing the lack of specific FDA approval, limited evidence, and high out-of-pocket costs. Future success depends on standardized, prospective RCTs and a collaborative \u201cmiddle-ground pathway\u201d for regulatory approval.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-25-01295","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:00:10Z","timestamp":1769547610000},"page":"e1878-e1886","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The Evidence Basis and Regulatory Framework for Biologic Augmentation of Foot and Ankle Surgeries"],"prefix":"10.5435","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6198-9233","authenticated-orcid":false,"given":"Edward T.","family":"Haupt","sequence":"first","affiliation":[{"name":"Mayo Clinic Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8764-8886","authenticated-orcid":false,"given":"Glenn G.","family":"Shi","sequence":"additional","affiliation":[{"name":"Mayo Clinic Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5753-0625","authenticated-orcid":false,"given":"Shane A.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Mayo Clinic Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"R1-20260701","first-page":"102162","article-title":"Concentrated bone marrow aspirate applications in bony fusion for foot and ankle orthopaedic surgery: A review","volume":"64","author":"Anastasio","year":"2025","journal-title":"Foot Edinb Scotl"},{"key":"R2-20260701","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.fcl.2016.07.005","article-title":"Bone marrow aspirate concentrate for bone healing in foot and ankle surgery","volume":"21","author":"Harford","year":"2016","journal-title":"Foot Ankle Clin"},{"key":"R3-20260701","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cpm.2020.03.012","article-title":"Bone grafting options","volume":"37","author":"Grambart","year":"2020","journal-title":"Clin Podiatr Med Surg"},{"key":"R4-20260701","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2106\/00004623-199711000-00012","article-title":"Aspiration to obtain osteoblast progenitor cells from human bone marrow: The influence of aspiration volume","volume":"79","author":"Muschler","year":"1997","journal-title":"J Bone Joint Surg Am"},{"key":"R5-20260701","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00264-023-05803-z","article-title":"Orthobiologics: A review","volume":"47","author":"Mavrogenis","year":"2023","journal-title":"Int Orthop"},{"key":"R6-20260701","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.fas.2013.08.001","article-title":"Platelet-rich plasma for foot and ankle pathologies: A systematic review","volume":"20","author":"Vannini","year":"2014","journal-title":"Foot Ankle Surg"},{"key":"R7-20260701","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.fas.2023.07.010","article-title":"The use of platelet-rich plasma in pathologies of the foot and ankle: A comprehensive review of the recent literature","volume":"29","author":"Bagheri","year":"2023","journal-title":"Foot Ankle Surg"},{"key":"R8-20260701","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4252\/wjsc.v13.i2.155","article-title":"Platelet-rich plasma vs bone marrow aspirate concentrate: An overview of mechanisms of action and orthobiologic synergistic effects","volume":"13","author":"Lana","year":"2021","journal-title":"World J Stem Cell"},{"key":"R9-20260701","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/10711007221119164","article-title":"Comparing rates of fusion and time to fusion in viable cellular allograft and autograft","volume":"43","author":"Frederick","year":"2022","journal-title":"Foot Ankle Int"},{"key":"R10-20260701","doi-asserted-by":"crossref","first-page":"103896","DOI":"10.1016\/j.otsr.2024.103896","article-title":"A systematic scoping review of the latest data on orthobiologics in the surgical treatment of non-union","volume":"110","author":"Gagnon","year":"2024","journal-title":"Orthopaedics Traumatol Surg Res"},{"key":"R11-20260701","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.fcl.2016.07.013","article-title":"Injectable recombinant human platelet-derived growth factor in collagen carrier for hindfoot fusion","volume":"21","author":"Dodd","year":"2016","journal-title":"Foot Ankle Clin"},{"key":"R12-20260701","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s11999-013-3261-7","article-title":"Recombinant human BMP-2 increases the incidence and rate of healing in complex ankle arthrodesis","volume":"472","author":"Fourman","year":"2014","journal-title":"Clin orthopaedics Relat Res"},{"key":"R14-20260701","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1016\/j.arthro.2025.01.062","article-title":"Biologic association member organization representatives: Experts achieve consensus on a majority of statements regarding ethics, transparency, regulation, and best practices for the use of orthobiologics","volume":"41","author":"Gilat","year":"2025","journal-title":"Arthroscopy"},{"key":"R15-20260701","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/15563316251361511","article-title":"Ethical and regulatory considerations related to regenerative medicine","volume":"21","author":"Jayaram","year":"2025","journal-title":"HSS J"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01295","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:49:03Z","timestamp":1787669343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":14,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-25-01295","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-10-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}